Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KNSA | AZN | AMGN | GILD | BMY |
| Company | Kiniksa Pharmaceuticals International Plc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 42.73 | 204.98 | 385.14 | 145.92 | 61.53 |
| High | 44.30 | 205.16 | 385.14 | 146.36 | 61.60 |
| Low | 42.42 | 202.64 | 374.25 | 143.09 | 60.65 |
| Latest | 43.49 | 203.98 | 379.33 | 143.77 | 61.10 |
| Change | +0.73 | -1.81 | -5.00 | -3.35 | -0.20 |
| % Change | +1.71% | -0.88% | -1.30% | -2.28% | -0.33% |
| Volume | 814,300 | 2,250,400 | 2,589,600 | 7,987,600 | 10,672,500 |
| 20-Day Average Volume | 565,940 | 2,624,730 | 3,006,485 | 7,788,930 | 13,764,439 |
| Previous Close | 42.76 | 205.79 | 384.33 | 147.12 | 61.30 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 44.68 | 197.98 | 367.91 | 148.81 | 59.44 |
| 20-Day Raw Stochastic | 29.63% | 69.98% | 83.49% | 29.07% | 87.10% |
| 20-Day Relative Strength | 49.74 | 59.99 | 62.28 | 53.40 | 64.07 |
| Weighted Alpha | +87.54 | +42.67 | +32.68 | +33.38 | +16.45 |
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 64% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.80% since 02/19/26 | -2.22% since 02/19/26 | +1.02% since 02/19/26 | -4.86% since 02/19/26 | +1.33% since 02/19/26 |
| Low | 41.12 on 02/24/26 | 202.64 on 02/26/26 | 371.39 on 02/20/26 | 143.09 on 02/26/26 | 59.65 on 02/20/26 |
| High | 49.12 on 02/23/26 | 209.35 on 02/24/26 | 387.49 on 02/25/26 | 153.26 on 02/20/26 | 62.12 on 02/25/26 |
| 1-Month | |||||
| %Chg | +0.67% since 01/26/26 | +8.24% since 01/26/26 | +8.48% since 01/26/26 | +4.35% since 01/26/26 | +11.90% since 01/26/26 |
| Low | 41.12 on 02/24/26 | 183.63 on 02/03/26 | 338.07 on 01/30/26 | 137.54 on 01/27/26 | 54.21 on 01/29/26 |
| High | 49.12 on 02/23/26 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| 3-Month | |||||
| %Chg | +2.23% since 11/26/25 | +9.29% since 11/26/25 | +10.09% since 11/26/25 | +12.75% since 11/26/25 | +24.06% since 11/26/25 |
| Low | 37.02 on 01/15/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 48.22 on 12/02/25 |
| High | 49.12 on 02/23/26 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| 6-Month | |||||
| %Chg | +29.55% since 08/26/25 | +27.41% since 08/26/25 | +30.99% since 08/26/25 | +25.29% since 08/26/25 | +29.42% since 08/26/25 |
| Low | 33.25 on 08/29/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 49.12 on 02/23/26 | 212.71 on 02/18/26 | 387.49 on 02/25/26 | 157.29 on 02/11/26 | 62.12 on 02/25/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,241,036 | 319,161,344 | 207,180,000 | 182,528,832 | 124,835,848 |
| Shares Outstanding, K | 75,796 | 1,550,908 | 539,068 | 1,240,680 | 2,036,474 |
| Annual Sales | 423,240,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -43,190,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 180,860,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 18,440,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.06 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.17 on 02/24/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 58.78 | 25.51 | 17.52 | 18.12 | 10.02 |